EAM Investors, LLC

SEC CIK: 0001510989
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

ACRS holding history

Aclaris Therapeutics, Inc. in every 13F filed by EAM Investors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACRS overview All 13F holders of ACRS Full Q2 2026 holdings

Shares (Q2 2026): 171,327
Value: $906.3K
% of portfolio: 0.1%
Quarters held: 3; Since Q1 2021

Holdings of ACRS by EAM Investors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	171,327	$906.3K	0.1%	−7,051−4.0%	Reduced	Holders
Q1 2026	178,378	$668.9K	0.1%	+178,378	New	Holders
Q2 2021	0	$0	0.0%	−205,295−100.0%	Sold out	Holders
Q1 2021	205,295	$5.17M	0.8%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.